ARCT vs TYL · rev $5.0M vs P/E 89, rev $1.26B
Arcturus Therapeutics Holdings Inc (ARCT) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
ARCT currently screens at market cap $369.4M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the ARCT and TYL stock pages for the full models.
Not investment advice.